Enabling NGS-based metagenomics in the clinical virology laboratory
Clinical Virology Symposium 2019 – Full WorkshopThis workshop was presented at the Clinical Virology Symposium on May 6th, 2019 by:
- Dr. Benjamin Pinsky of Stanford Health Care and Stanford Children’s Clinic
- Dr. Julianne Brown of Great Ormond Street Hospital for Children NHS Foundation Trust
- Dr. Jesus Ching, Senior Vice President of R&D at Arc Bio.
The workshop examines the use of NGS-based metagenomics as a platform for pathogen detection in the clinical virology laboratory.
In these workshop presentations you will learn:
- What is NGS-based metagenomics (mNGS) is and how it can be applied to pathogen detection
- How mNGS compares with and improves upon qPCR as a detection platform
- What the mNGS workflow looks like when deployed in your laboratory
- Why deploying mNGS into your laboratory makes sense
- How mNGS has been used to identify unexpected and novel pathogens related to viral encephalitis
- How mNGS identified additional viruses missed by conventional qPCR in over 50% of samples
- How to validate mNGS-based assays in your laboratory
- How Arc Bio has approached mNGS with its Galileo™ platform
Dr. Benjamin Pinsky
Medical Director, Clinical Virology,
Stanford Health Care and Stanford Children’s Health
Evaluation of the Galileo™ Pathogen Solution Next- Generation Sequencing Pipeline for the Detection and Quantitation of DNA Viruses in Immunocompromised Hosts
Dr. Julianne Brown
Clinical Scientist,
Great Ormond Street Hospital for Children NHS Foundation Trust
How can we use metagenomics for the diagnosis and management of patients?
Dr. Jesus Ching
Senior VP R&D, Arc Bio LLC
Introduction to the Galileo™ Pathogen Solution platform
Workshop Video (1 hour 21 minutes):
Dr. Jesus Ching’s Slides (20 slides):
Dr. Ben Pinsky’s Slides (17 slides):
Dr. Julianne Brown’s Slides (21 slides):
